Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10045141HBVENSG00000110799.14protein_codingVWFNoNo7450P04275
TVIS10045142HBVENSG00000110799.14protein_codingVWFNoNo7450P04275
TVIS30078176HIVENSG00000110799.14protein_codingVWFNoNo7450P04275
TVIS30031856HIVENSG00000110799.14protein_codingVWFNoNo7450P04275
TVIS20031407HPVENSG00000110799.14protein_codingVWFNoNo7450P04275
TVIS44014045HTLV-1ENSG00000110799.14protein_codingVWFNoNo7450P04275
TVIS44017512HTLV-1ENSG00000110799.14protein_codingVWFNoNo7450P04275
TCGA Plot Options
Drug Information
GeneVWF
DrugBank IDDB00025
Drug NameAntihemophilic factor, human recombinant
Target IDBE0001043
UniProt IDP04275
Regulation Typebinder
PubMed IDs10938981; 11858481; 14750934; 2128855; 2942172
CitationsShord SS, Lindley CM: Coagulation products and their uses. Am J Health Syst Pharm. 2000 Aug 1;57(15):1403-17; quiz 1418-20.@@Lillicrap D, Poon MC, Walker I, Xie F, Schwartz BA: Efficacy and safety of the factor VIII/von Willebrand factor concentrate, haemate-P/humate-P: ristocetin cofactor unit dosing in patients with von Willebrand disease. Thromb Haemost. 2002 Feb;87(2):224-30.@@Gill JC, Ewenstein BM, Thompson AR, Mueller-Velten G, Schwartz BA: Successful treatment of urgent bleeding in von Willebrand disease with factor VIII/VWF concentrate (Humate-P): use of the ristocetin cofactor assay (VWF:RCo) to measure potency and to guide therapy. Haemophilia. 2003 Nov;9(6):688-95.@@Smith KJ, Lusher JM, Cohen AR, Salzman P: Initial clinical experience with a new pasteurized monoclonal antibody purified factor VIIIC. Semin Hematol. 1990 Apr;27(2 Suppl 2):25-9.@@Altieri DC, Capitanio AM, Mannucci PM: von Willebrand factor contaminating porcine factor VIII concentrate (Hyate:C) causes platelet aggregation. Br J Haematol. 1986 Aug;63(4):703-11.
GroupsApproved; Investigational
Direct ClassificationPeptides
SMILES
Pathways
PharmGKBPA164750168
ChEMBLCHEMBL2108175